Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page previously displaying a study record now shows a 403 Forbidden error, with site chrome (navigation/footer) still visible, indicating the content is temporarily inaccessible.SummaryDifference19%

- Check36 days agoChange DetectedA new NIH grant/contract identifier was added to the study's identifiers, and the page revision was updated to v3.6.6.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a minor platform update rather than changes to user-facing content.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.6.4 is now shown in the page footer, replacing the previous v3.6.3. This reflects a minor version update to the site's interface rather than changes to the study data.SummaryDifference0.0%

- Check93 days agoChange DetectedThe website now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision identifier rather than to study data or content.SummaryDifference0.0%

- Check100 days agoChange DetectedAn updated software build identifier (v3.6.2) is now displayed on the page, replacing the previous v3.6.0. This appears to be routine page maintenance and does not modify the study information or visible content.SummaryDifference0.0%

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.